Fusobacterium nucleatum induces excess methyltransferase-like 3-mediated microRNA-4717-3p maturation to promote colorectal cancer cell proliferation

Fusobacterium nucleatum infection plays vital roles in colorectal cancer (CRC) progression. Overexpression of microRNA-4717-3p (miR-4717) was reported to be upregulated in F. nucleatum positive CRC tissues, however, the underlying mechanism is unknown. In this study, we found that miR-4717 promoted CRC cell proliferation in vitro and growth of CRC in vivo following F. nucleatum infection. MicroRNA-4717 suppressed the expression of mitogen-activated protein kinase kinase 4 (MAP2K4), a tumor suppressor, by directly targeting its 3 '-UTR. Furthermore, we confirmed that methyltransferase-like 3 (METTL3)-dependent m(6)A methylation could methylate primary (pri)-miR-4717, which further promoted the maturation of pri-miR-4717, and METTL3 positively regulated CRC cell proliferation through miR-4717/MAP2K4 pathways. In conclusion, F. nucleatum-induced miR-4717 excessive maturation through METTL3-dependent m(6)A modification promotes CRC cell proliferation, which provides a potential therapeutic target and diagnostic biomarker for CRC.

Automated summary

This study reveals that Fusobacterium nucleatum infection promotes colorectal cancer (CRC) progression by upregulating microRNA-4717-3p (miR-4717) expression. MiR-4717 enhances CRC cell proliferation by directly inhibiting tumor suppressor MAP2K4. Additionally, METTL3-dependent m(6)A methylation facilitates the maturation of pri-miR-4717, which further promotes CRC cell proliferation through the miR-4717/MAP2K4 pathway.